Literature DB >> 18299580

Both ovarian hormones estrogen and progesterone are necessary for hormonal mammary carcinogenesis in ovariectomized ACI rats.

Edward W Blank1, Po-Yin Wong, Rajkumar Lakshmanaswamy, Raphael Guzman, Satyabrata Nandi.   

Abstract

August-Copenhagen-Irish (ACI) rats are unique in that the ovary-intact females develop high incidence of mammary cancers induced solely by hormones upon prolonged exposure to high levels of estrogen alone. Studies have also shown that such prolonged exposure to high-dose estrogen results in human-like aneuploid mammary cancers in ovary-intact ACI rats. To determine the role of progesterone in mammary carcinogenesis, six-week-old intact and ovariectomized ACI rats were continuously exposed to low- and high-dose estrogen alone, progesterone alone, low-dose estrogen plus progesterone, and ovariectomized ACI rats with high-dose estrogen plus progesterone. Also, ovariectomized ACI rats were treated with high-dose estrogen plus progesterone plus testosterone to determine the role of the androgen, testosterone, if any, in hormonal mammary carcinogenesis. The results indicate that continuous exposure to high, but not low, concentrations of estrogen alone can induce mammary carcinogenesis in intact but not in ovariectomized rats. Mammary carcinogenesis in ovariectomized ACI rats requires continuous exposure to high concentrations of estrogen and progesterone. The addition of testosterone propionate does not affect tumor incidence in such rats. These results suggest that both ovarian hormones estrogen and progesterone are necessary for mammary carcinogenesis induced solely by hormones in ovariectomized ACI rats. Our results are in agreement with the Women's Health Initiative studies, where treatment of postmenopausal women with estrogen (ERT) alone did not increase the risk of breast cancer, but estrogen and progesterone (HRT) did.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18299580      PMCID: PMC2265202          DOI: 10.1073/pnas.0710535105

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  47 in total

1.  Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.

Authors:  J D Shull; T J Spady; M C Snyder; S L Johansson; K L Pennington
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

2.  Cumulative absolute breast cancer risk for young women treated for Hodgkin lymphoma.

Authors:  Lois B Travis; Deirdre Hill; Graça M Dores; Mary Gospodarowicz; Flora E van Leeuwen; Eric Holowaty; Bengt Glimelius; Michael Andersson; Eero Pukkala; Charles F Lynch; David Pee; Susan A Smith; Mars B Van't Veer; Timo Joensuu; Hans Storm; Marilyn Stovall; John D Boice; Ethel Gilbert; Mitchell H Gail
Journal:  J Natl Cancer Inst       Date:  2005-10-05       Impact factor: 13.506

3.  Non-dietary factors as risk factors for breast cancer, and as effect modifiers of the association of fat intake and risk of breast cancer.

Authors:  D J Hunter; D Spiegelman; H O Adami; P A van den Brandt; A R Folsom; R A Goldbohm; S Graham; G R Howe; L H Kushi; J R Marshall; A B Miller; F E Speizer; W Willett; A Wolk; S S Yaun
Journal:  Cancer Causes Control       Date:  1997-01       Impact factor: 2.506

4.  Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.

Authors:  D M Harvell; T E Strecker; M Tochacek; B Xie; K L Pennington; R D McComb; S K Roy; J D Shull
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

Review 5.  Dynamics of steroid hormone receptor action.

Authors:  B S Katzenellenbogen
Journal:  Annu Rev Physiol       Date:  1980       Impact factor: 19.318

6.  Hormonal prevention of breast cancer: mimicking the protective effect of pregnancy.

Authors:  R C Guzman; J Yang; L Rajkumar; G Thordarson; X Chen; S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1999-03-02       Impact factor: 11.205

7.  Increased cell division as a cause of human cancer.

Authors:  S Preston-Martin; M C Pike; R K Ross; P A Jones; B E Henderson
Journal:  Cancer Res       Date:  1990-12-01       Impact factor: 12.701

8.  Modulation of rat uterine steroid hormone receptors by estrogen and antiestrogen.

Authors:  C J Dix; V C Jordan
Journal:  Endocrinology       Date:  1980-12       Impact factor: 4.736

9.  Relationship between long durations and different regimens of hormone therapy and risk of breast cancer.

Authors:  Christopher I Li; Kathleen E Malone; Peggy L Porter; Noel S Weiss; Mei-Tzu C Tang; Kara L Cushing-Haugen; Janet R Daling
Journal:  JAMA       Date:  2003-06-25       Impact factor: 56.272

10.  Serum sex hormone levels after menopause and subsequent breast cancer.

Authors:  F Berrino; P Muti; A Micheli; G Bolelli; V Krogh; R Sciajno; P Pisani; S Panico; G Secreto
Journal:  J Natl Cancer Inst       Date:  1996-03-06       Impact factor: 13.506

View more
  19 in total

1.  The chemopreventive effect of mifepristone on mammary tumorigenesis is associated with an anti-invasive and anti-inflammatory gene signature.

Authors:  Hongyan Yuan; Geeta Upadhyay; Jin Lu; Levy Kopelovich; Robert I Glazer
Journal:  Cancer Prev Res (Phila)       Date:  2012-03-16

2.  The induction of KLF5 transcription factor by progesterone contributes to progesterone-induced breast cancer cell proliferation and dedifferentiation.

Authors:  Rong Liu; Zhongmei Zhou; Dong Zhao; Ceshi Chen
Journal:  Mol Endocrinol       Date:  2011-05-12

Review 3.  NO to breast: when, why and why not?

Authors:  Shehla Pervin; Gautam Chaudhuri; Rajan Singh
Journal:  Curr Pharm Des       Date:  2010       Impact factor: 3.116

4.  Immune response to a model shared placenta/tumor-associated antigen reduces cancer risk in parous mice.

Authors:  Susmita Jasti; Mina Farahbakhsh; Sean Nguyen; Brian K Petroff; Margaret G Petroff
Journal:  Biol Reprod       Date:  2017-01-01       Impact factor: 4.285

5.  Mapping of three genetic determinants of susceptibility to estrogen-induced mammary cancer within the Emca8 locus on rat chromosome 5.

Authors:  Beverly S Schaffer; Kristin M Leland-Wavrin; Scott G Kurz; John A Colletti; Nicole L Seiler; Christopher L Warren; James D Shull
Journal:  Cancer Prev Res (Phila)       Date:  2012-11-14

Review 6.  Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Authors:  James D Shull; Kirsten L Dennison; Aaron C Chack; Amy Trentham-Dietz
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

7.  Equine estrogen-induced mammary tumors in rats.

Authors:  Yoshinori Okamoto; Xiaoping Liu; Naomi Suzuki; Kanako Okamoto; Hyo Jeong Kim; Y R Santosh Laxmi; Kazutoshi Sayama; Shinya Shibutani
Journal:  Toxicol Lett       Date:  2010-01-22       Impact factor: 4.372

8.  Prevention of hormonal breast cancer by dietary jamun.

Authors:  Farrukh Aqil; Jeyaprakash Jeyabalan; Radha Munagala; Inder Pal Singh; Ramesh C Gupta
Journal:  Mol Nutr Food Res       Date:  2016-04-21       Impact factor: 5.914

9.  Tamoxifen induces regression of estradiol-induced mammary cancer in the ACI.COP-Ept2 rat model.

Authors:  Rachel L Ruhlen; Dana M Willbrand; Cynthia L Besch-Williford; Lixin Ma; James D Shull; Edward R Sauter
Journal:  Breast Cancer Res Treat       Date:  2008-09-09       Impact factor: 4.872

10.  Crosstalk between progesterone receptor membrane component 1 and estrogen receptor α promotes breast cancer cell proliferation.

Authors:  Diego A Pedroza; Ramadevi Subramani; Kira Tiula; Anthony Do; Navya Rashiraj; Adriana Galvez; Animesh Chatterjee; Alejandra Bencomo; Servando Rivera; Rajkumar Lakshmanaswamy
Journal:  Lab Invest       Date:  2021-04-26       Impact factor: 5.662

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.